(R)-2-Methylbut-3-Enoic Acid: A Crucial Pharmaceutical Intermediate for Milvexian Synthesis
(R)-2-Methylbut-3-Enoic Acid, CAS No. 20626-49-7, is a high-purity intermediate vital for advanced pharmaceutical research.
Get a Quote & SampleProduct Core Value
(R)-2-Methylbut-3-Enoic Acid
This critical pharmaceutical intermediate boasts exceptional purity of over 98% and holds prestigious certifications including GMP, ISO 9001, and FDA compliance. Its primary application lies in the complex synthesis pathways for advanced pharmaceutical compounds, most notably as a key building block for Milvexian, an investigational oral Factor XIa inhibitor. The reliable supply of high-quality (R)-2-Methylbut-3-Enoic Acid is instrumental in the development of novel therapeutics targeting cardiovascular conditions.
- Leveraging (R)-2-Methylbut-3-Enoic Acid intermediate for Milvexian synthesis ensures high-quality drug development.
- CAS No. 20626-49-7: A critical identifier for this high-purity chemical intermediate.
- This GMP, ISO 9001 certified chemical intermediate guarantees reliability in pharmaceutical research.
- Utilizing high-purity (>98%) intermediates is essential for the successful synthesis of Factor XIa inhibitors.
Advantages Provided by the Product
Uncompromised Purity for Research
Ensuring the successful synthesis of Factor XIa inhibitors relies on the high purity (>98%) of intermediates like (R)-2-Methylbut-3-Enoic Acid.
Certified Quality Assurance
GMP, ISO 9001, and FDA certifications for this pharmaceutical intermediate provide confidence in its quality and suitability for demanding research applications.
Crucial for Novel Therapeutics
The role of (R)-2-Methylbut-3-Enoic Acid in Milvexian synthesis underscores its importance in developing next-generation cardiovascular treatments.
Key Applications
Pharmaceutical Synthesis
As a key building block, (R)-2-Methylbut-3-Enoic Acid is fundamental in the complex synthesis of active pharmaceutical ingredients.
Milvexian Intermediate
This chemical compound serves as an indispensable intermediate in the manufacturing process of Milvexian, a promising Factor XIa inhibitor.
Scientific Research
Its high purity and reliable quality make it a preferred chemical medicine intermediate for various scientific research endeavors.
Drug Development
Vital for the development of novel therapeutics, particularly those targeting cardiovascular diseases like thrombotic conditions.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).